A comparison of enprofylline and theophylline in the maintenance therapy of chronic reversible obstructive airway disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A comparison of enprofylline and theophylline in the maintenance therapy of chronic reversible obstructive airway disease

Published:1990-02 Issue:2 Volume:85 Page:514-521
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Chapman K.R.,Boucher S.,Hyland R.H.,Day A.,Kreisman H.,Rivington R.,Hodder R.V.,York E.L.,Abboud R.T.,Peters S.,Wolkove N.,Freeman D.

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference18 articles.

1. Enprofylline, a principally new anti-asthmatic xanthine;Persson;Acta Pharmacol Toxicol,1981

2. Effects of enprofylline, a xanthine lacking adenosine antagonism, in patients with reversible obstructive lung diseases;Lunell;Eur J Clin Pharmacol,1982

3. Intravenous enprofylline in asthma patients;Lunell;Eur J Respir Dis,1984

4. Adenosine antagonism, a less desirable characteristic of xanthine asthma drugs?;Persson;Acta Pharmacol Toxicol,1981

5. A placebo-controlled dose-response study of enprofylline in the maintenance therapy of asthma;Chapman;Am Rev Respir Dis,1989

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vivoobservations provide insight into roles of eosinophils and epithelial cells in asthma;European Respiratory Journal;2019-06-27

2. Oral theophylline for chronic obstructive pulmonary disease;Cochrane Database of Systematic Reviews;2002-10-21

3. Long-Term Xanthine Therapy of Asthma;Chest;1994-11

4. A Rapid Monoclonal Antibody Blood Theophylline Assay Lack of Cross-Reactivity with Enprofylline;Therapeutic Drug Monitoring;1994-06

5. Can fatal asthma be prevented?-a personal view;Clinical Experimental Allergy;1992-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3